Skin neoplasm
MONDO:0002531A benign or malignant tumor involving the skin. Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma. Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.
Also known as: neoplasm of skin, neoplasm of the skin, neoplasm of zone of skin, skin neoplasm, skin neoplasms, skin tumor, skin tumour, tumor of skin
2386 clinical trials for this condition and its sub-types, 170 tagged with Skin neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin neoplasm
-
Skin cancer 118 trials · 801 incl. sub-types
13 sub-types
- Cutaneous melanoma 273 trials · 285 incl. sub-types Sub-types →
- Skin carcinoma 35 trials · 283 incl. sub-types Sub-types →
- Primary cutaneous lymphoma 6 trials · 134 incl. sub-types Sub-types →
- Malignant dermis tumor 0 trials · 87 incl. sub-types Sub-types →
- CD4+/CD56+ hematodermic neoplasm 31 trials
- Eyelid cancer 3 trials · 4 incl. sub-types Sub-types →
- Sebaceous gland cancer 0 trials · 3 incl. sub-types Sub-types →
- Sweat gland cancer 1 trial · 2 incl. sub-types Sub-types →
- Cutaneous ganglioneuroma 0 trials
- Labia minora cancer 0 trials Sub-types →
- Labium majus cancer 0 trials Sub-types →
- Prepuce cancer 0 trials
- Skin meningioma 0 trials Sub-types →
-
Melanocytic skin neoplasm 2 trials · 359 incl. sub-types
2 sub-types
- Cutaneous melanoma 273 trials · 285 incl. sub-types Sub-types →
- Melanocytic nevus 17 trials · 77 incl. sub-types Sub-types →
-
Epithelial skin neoplasm 0 trials · 313 incl. sub-types
5 sub-types
- Skin carcinoma 35 trials · 283 incl. sub-types Sub-types →
- Benign epithelial skin neoplasm 0 trials · 30 incl. sub-types Sub-types →
- Keratoacanthoma 1 trial Sub-types →
- Sebaceous adenoma 0 trials
- Sweat gland adenoma 0 trials Sub-types →
-
Benign neoplasm of skin 3 trials · 118 incl. sub-types
12 sub-types
- Melanocytic nevus 17 trials · 77 incl. sub-types Sub-types →
- Benign epithelial skin neoplasm 0 trials · 30 incl. sub-types Sub-types →
- Skin hemangioma 2 trials · 7 incl. sub-types Sub-types →
- Leiomyoma cutis 2 trials Sub-types →
- Benign eyelid neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Skin lipoma 1 trial
- Bacillary angiomatosis 0 trials
- Benign neoplasm of sebaceous gland 0 trials
- Benign neoplasm of sweat gland 0 trials Sub-types →
- Encephalocraniocutaneous lipomatosis 0 trials
- Familial multiple fibrofolliculoma 0 trials
- Skin lymphangioma 0 trials
-
Dermis tumor 0 trials · 90 incl. sub-types
8 sub-types
- Malignant dermis tumor 0 trials · 87 incl. sub-types Sub-types →
- Leiomyoma cutis 2 trials Sub-types →
- Cutaneous fibrous histiocytoma 1 trial
- Cutaneous granular cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Cutaneous mastocytosis 1 trial Sub-types →
- Skin glomus tumor 1 trial Sub-types →
- Angioma serpiginosum 0 trials Sub-types →
- Juvenile hyaline fibromatosis 0 trials
-
Actinic keratosis 41 trials
-
Epidermal appendage tumor 3 trials · 8 incl. sub-types
5 sub-types
- Skin appendage carcinoma 4 trials · 6 incl. sub-types Sub-types →
- Sebaceous gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Sweat gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Hair follicle neoplasm 0 trials Sub-types →
- Hamartoma of skin appendage 0 trials Sub-types →
-
Eyelid neoplasm 3 trials · 7 incl. sub-types
3 sub-types
- Palpebral epidermal tumor 0 trials · 5 incl. sub-types Sub-types →
- Benign eyelid neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Neurogenic palpebral tumor 0 trials
-
Schwannomatosis 3 trials
4 sub-types
- 22q-related schwannomatosis 0 trials
- LZTR1-related schwannomatosis 0 trials
- SMARCB1-related schwannomatosis 0 trials
- Neurofibromatosis, type III, mixed central and peripheral 0 trials
-
Maffucci syndrome 2 trials
-
Benign dermal neurilemmoma 0 trials
-
Dermoid cyst of skin 0 trials
-
Familial Dupuytren contracture 0 trials
-
Familial multiple discoid fibromas 0 trials
-
Hemangiopericytoma of skin 0 trials
Most studied deeper sub-types
-
Early trial of experimental cancer combo halted after just 6 patients
Disease control Stopped earlyThis early-phase study tested a new drug called PF-08046032, given alone or with another drug (sasanlimab), in adults with advanced lymphomas or solid tumors like lung cancer and melanoma. The trial aimed to check safety and find the right dose, but it was terminated early after …
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Personalized mRNA cancer vaccine trial halted midway
Disease control Stopped earlyThis study tested a personalized mRNA vaccine (mRNA-4157) combined with the immunotherapy drug pembrolizumab for people with advanced but removable skin cancer (cutaneous squamous cell carcinoma). The goal was to see if the combination could prevent the cancer from coming back be…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Melanoma drug combo study halted before full results
Disease control Stopped earlyThis study tested a combination of two drugs, ipilimumab and epacadostat, in people with advanced melanoma that could not be removed by surgery or had spread. The goal was to see if adding epacadostat to standard treatment improved survival. However, the study was stopped early f…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Three-Drug cocktail takes on tough melanoma
Disease control Stopped earlyThis study tested whether a three-drug combination (encorafenib, binimetinib, and pembrolizumab) works better than a two-drug combo (ipilimumab and nivolumab) for people with advanced melanoma that has a BRAF mutation and has already been treated with anti-PD-1 therapy. The trial…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Radioactive seeds zapped tumors from the inside — but trial stopped early
Disease control Stopped earlyThis early study tested a device that places radioactive seeds directly into skin, mouth, or soft tissue tumors. The seeds release alpha radiation to kill cancer cells from within. Only 2 people took part before the trial was stopped, so we don't have enough information to know i…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Triple therapy for melanoma: hope or hype?
Disease control Stopped earlyThis phase 3 study tested whether adding an immunotherapy drug (spartalizumab) to two targeted therapy drugs (dabrafenib and trametinib) works better than the targeted drugs alone for people with advanced BRAF V600 mutant melanoma. The trial enrolled 568 participants but was term…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 18:27 UTC
-
AI mole checker tested at home – but trial stops early
Diagnosis Stopped earlyThis study tested whether a device called the Sklip System, which uses artificial intelligence, could help people at home decide if a mole might be skin cancer. Only one person took part before the study was stopped early. The goal was to see if the AI could match or beat standar…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Tiny study tests oxygen measurement in skin cancers
Knowledge-focused Stopped earlyThis study tested a method called EPR oximetry to measure oxygen levels in skin tumors. Only 3 people took part before the study was stopped early. The goal was to see if this technique could track how tumors respond to oxygen therapy and standard cancer treatments.
Sponsor: West Virginia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC